- Product Details
- Reviews & Citations
TIGIT has been shown to be over expressed on tumor antigen-specific CD8+ T cells and CD8+ tumor infiltrating lymphocytes (TIL). Blockade of TIGIT led to increased cell proliferation, cytokine production, and degranulation of TA-specific CD8+ T cells and TIL CD8+ T cells, which now make it be considered as an immune checkpoint. Recently, studies have shown anti-TIGIT antibody is promising to become a cancer immunotherapy. Our ELISA kit is designed to help the discovery of anti-TIGIT therapeutic antibody.
It is for research use only.
See Certificate of Analysis for details of reconstitution instruction and specific concentration.
Upon receipt, please store the lyophilized products at -20°C. After reconstitution, the stock solution should be kept at -70°C. Upon receipt, please store the plate at Room Temperature, and please store the buffer at -20°C.
Try to avoid more than 3 freeze thaw cycles.
No activity loss is observed after storage at: Room temperature (RT) for 1 month in lyophilized state; -20°C for 1 year in lyophilized state; -70°C for 6 months under sterile conditions after reconstitution.
0